Published on September 30, 2015

Mayor Janice S. Mironov stated that Hovione yesterday announced that it will be undertaking a major expansion of their East Windsor facility, located at 40 Lake Drive, in the vicinity of East Windsor NJ Turnpike Exit 8.

Hovione, headquartered in Portugal, indicated that the expansion will add an additional 30,600 square feet to the existing 24,000 square foot facility. It will introduce a new commercial spray dryer unit to complement their existing pilot unit and this installation will be specifically designed to handle intermediate drug products. In addition the expansion will more than double the drug substance capacity at the site to support the needs of the current and future customer base. The expansion is expected to add approximately 60 new jobs to the current workforce.

Mayor Mironov stated, “The Hovione expansion plan is great news for the Township and another sign of our business vibrancy. This expansion marks a significant investment by Hovione in East Windsor, bringing new tax dollars, ensuring existing jobs and adding a large number of new jobs to our community. We are gratified that Hovione has found East Windsor to be such a beneficial home for their business, and that their business is on such a positive growth pathway here.” Mayor Mironov continued, “Hovione represents for East Windsor another high-tech, high growth pharmaceutical-related company in keeping with our Einstein’s Alley designation and vision.”

“Expanding our manufacturing presence in the USA highlights our commitment to our customers that want to manufacture their products in the US and to support the development needs of our ever expanding local customer base. The additional capacity will give us more flexibility and make us more agile to deal with our customer’s fast- paced projects.” said Dr. Marco Gil, General Manager, Hovione New Jersey.

“This investment pays a tribute to the excellent work that Hovione’s New Jersey team has done to create a sustainable business for the company in the US. We trust the team in New Jersey to be an integral part of Hovione’s overall expansion. ” said Dave Hoffman, President of the US Operations. “The State and especially the local government have been extremely supportive of us in the past and in our growth plans for the future and we are excited to partner with them to create new jobs in the local community.”

According to Hovione, this investment is part of the company’s strategy to increase its global development and commercial capacity to meet the increasing demands of Hovione’s customers.

The official ground breaking should occur in the first quarter of 2016 and the doubling of capacity is expected to be fully operational in early 2017.

Hovione is an international company with over 50 years’ experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates, and has four FDA inspected sites in the U.S., China, Ireland, and Portugal.